Pharmaceutical Technology

MAY 19, 2023

Whilst there is a range of FDA-approved biologics for Crohn’s disease, Rinvoq is the first approved oral product for the moderate to severe type of the disease. The FDA nod means Rinvoq is now approved for seven indications in gastroenterology, rheumatology and dermatology. A maintenance study showed the same effects at 52 weeks.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264

Fierce Pharma

JUNE 20, 2024

It's also Botanix's first approved product. . | The med is the first new chemical entity to win FDA approval specifically to treat primary axillary hyperhidrosis, or excessive underarm sweating.

FDA Approval 79

FDA Approval Dermatology Production 79

Pharmaceutical Technology

FEBRUARY 28, 2023

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

Pharmaceutical Technology

APRIL 17, 2023

Australian pharmaceutical company Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and the European Union (EU). In 2022, the company acquired CannQuit and ReneCann products as part of the acquisition of APIRx Pharmaceuticals.

Dermatology 130

Dermatology Clinical Trials Clinical Trials Production 130

BioTech 365

AUGUST 3, 2021

Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services and Grows Its Position in Dermatology Drug Testing Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services … Continue reading →

Cosmetics 40

Cosmetics Dermatology Production Drugs 40

Olympian Clinical Research

FEBRUARY 13, 2024

When it comes to maintaining healthy, vibrant skin, the choice of skincare products plays a pivotal role. At Academic Alliance in Dermatology, we understand the importance of using products that not only care for your skin on the surface but also work effectively at a cellular level.

Production 52

Production Dermatology Branding Containment 52

BioTech 365

MARCH 31, 2021

Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx … Continue reading →

Dermatology 40

Dermatology Production 40

Pharmaceutical Technology

DECEMBER 5, 2022

Incyte has signed a partnership and licence agreement with CMS subsidiary CMS Aesthetics to develop and market ruxolitinib cream to treat autoimmune and inflammatory dermatologic ailments in Greater China and some Southeast Asian countries. Incyte will also receive royalty payments on the net product sales in the territory of CMS.

Dermatology 130

Dermatology FDA Approval Production Sales 130

pharmaphorum

SEPTEMBER 15, 2022

.” The Swiss Competition Commission (COMCO) arrived unexpectedly at Novartis at dawn on Tuesday morning, to gather information on an unidentified dermatology drug, as part of a wider investigation into the drugmaker by the European Commission.

Dermatology 118

Dermatology Production Pharma Companies Marketing 118

Scienmag

MARCH 25, 2022

The data will be presented at the American Academy of Dermatology (AAD) Annual Meeting from March 25-29, 2022, in Boston. DURHAM, N.C., March 25, 2022 – Burt’s Bees, a pioneer in nature-based skin care, announced its latest research findings on the efficacy of natural origin skincare regimens.

Dermatology 54

Dermatology Research Production 54

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company offers consumer, prescription and automation products. Its investigational medicinal products comprise R-107, R-131 and R-147.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company offers consumer, prescription and automation products. Its investigational medicinal products comprise R-107, R-131 and R-147.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being.

Dermatology 100

Dermatology Trials Drugs Development 100

BioTech 365

MAY 11, 2021

Galderma Launches CETAPHIL® Line for Sensitive Skin and New DAYLONG® Sun Protection Product in Switzerland Galderma Launches CETAPHIL® Line for Sensitive Skin and New DAYLONG® Sun Protection Product in Switzerland CETAPHILquality dermatology line for sensitive skin is now available in … Continue reading →

Production 40

Production Dermatology 40

XTalks

MARCH 6, 2023

to acquire Mayne Pharma’s US generic prescription products portfolio. The portfolio contains approximately forty-five commercial products, four products in the pipeline, and forty approved non-marketed products, many of which are generics focused on women’s health. The portfolio includes some high entry-barrier products.

Production 98

Production Branding Dermatology Hormones 98

Pharmaceutical Technology

FEBRUARY 28, 2023

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

XTalks

JULY 16, 2021

The company said that while benzene is not an ingredient in any of its sunscreen products, it was detected during routine internal testing in some samples of its aerosol sunscreen finished products. Related: Google Launches AI-Based Dermatology Assist Tool. Benzene is a colorless flammable liquid that has a sweet odor.

Contamination 105

Contamination Production Drugs Branding 105

BioTech 365

SEPTEMBER 9, 2020

Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, oral, nasal, and eye care and dermatological conditions, and its New Zealand … Continue reading → .–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc.

Dermatology 40

Dermatology Production Development 40

Roots Analysis

FEBRUARY 22, 2024

Several companies have developed and are developing advanced wound care products to overcome these challenges. Evolution of Wound Care Management: Emergence of Advanced Wound Care Products Gauze, bandages, fabric, lint, and cotton products have always been the go to options for wound care.

Production 40

Production Dermatology Marketing Development 40

XTalks

JUNE 26, 2024

This condition profoundly impacts patients’ quality of life, affecting work productivity, daily activities, emotional well-being and personal relationships. Hyperhidrosis is the third most prevalent dermatological condition in the US, affecting roughly 15.3 million people, following acne and atopic dermatitis.

Clinical Trials 103

Clinical Trials Clinical Trials Dermatology FDA Approval 103

XTalks

MAY 22, 2023

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

Olympian Clinical Research

MAY 7, 2024

A common question we hear at Academic Alliance in Dermatology is: “How long do fillers last?” Popular Brands and Their Benefits Each brand offers products designed for specific needs: Juvéderm ® : Known for its smooth texture, Juvéderm works well for adding cheek volume, smoothing lines, and enhancing lips.

Filler 52

Filler Dermatology Branding Production 52

Olympian Clinical Research

MARCH 6, 2024

At Academic Alliance in Dermatology , we combine advanced technology, medication, and tailored skincare routines to effectively manage rosacea symptoms. Techniques like Intense Pulsed Light ( IPL ) therapy and Broad Band Light ( BBL ) therapy are both effective options offered at Academic Alliance in Dermatology.

Dermatology 52

Dermatology Production Development 52

Olympian Clinical Research

MAY 20, 2024

At Academic Alliance in Dermatology , we believe in providing treatments that enhance natural beauty. These micro-injuries stimulate the skin’s natural healing process, leading to the production of new collagen and elastin. What is Microneedling with PRP? 6 Benefits of Microneedling with PRP 1. Ready to Transform Your Skin?

Dermatology 52

Dermatology Production 52

The Pharma Data

OCTOBER 1, 2021

The research, which spans clinical, health economics and outcomes research, translational, clinical pharmacology and preclinical presentations, highlights the breadth and depth of the company’s data on deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor, also because the emerging dermatology pipeline.

Dermatology 52

Dermatology Trials Research Clinical Development 52

Olympian Clinical Research

MARCH 1, 2024

If you are wondering how to remove age spots, Academic Alliance in Dermatology can help. Ways to Remove Age Spots At Academic Alliance in Dermatology, we specialize in advanced, professional treatments to effectively reduce age spots, ensuring our patients receive the highest standard of care. What are Age Spots?

Dermatology 52

Dermatology Production Cosmetics Hormones 52

pharmaphorum

SEPTEMBER 8, 2022

As yet, no new medical product has been approved on the basis of a digital endpoint. It is hoped today’s event will serve as a “blueprint for the broader development and deployment of digital endpoints in medical product development”.

Dermatology 52

Dermatology Production Radiology Development 52

pharmaphorum

DECEMBER 29, 2021

The green light comes later than Leo hoped, as the FDA turned down the dermatology specialist’s first attempt last year, despite making it through regulatory reviews in the EU, UK, Canada and UAE where it is already launched as Adtralza. Leo now says it will start rolling the new product out in February. billion in 2020.

Sales 111

Sales Dermatology Marketing Allergies 111

XTalks

AUGUST 7, 2023

Verrica, a company specializing in dermatology therapeutics, has designed Ycanth to be delivered through a single-use applicator. Therefore, care must be taken to avoid fire, flames or smoking near the lesion(s) during treatment and after application until the product has been removed. What is Molluscum Contagiosum?

FDA Approval 98

FDA Approval Dermatology Trials Clinical Trials 98

The Pharma Data

NOVEMBER 8, 2020

Almirall strengthens its leadership in medical dermatology by reinforcing its management team in France and obtaining reimbursement in France of Ilumetri ® (tildrakizumab) for treating moderate to severe chronic plaque psoriasis in adults. Dermatology shows resilience in Europe and initial signs of recovery in the US.

Dermatology 52

Dermatology Sales Marketing Production 52

The Pharma Data

NOVEMBER 26, 2020

In 2019 Enova added quality, luxury loupes to their line of products. Based in Minneapolis, Minnesota , Enova has been innovating and mastering LED illumination for over 13 years for a variety of surgical practices. ” Visit www.goenova.com for more information. . . SOURCE Enova Illumination.

Cosmetics 52

Cosmetics Dermatology Doctors Doctor 52

Olympian Clinical Research

APRIL 9, 2024

At Academic Alliance in Dermatology , we are proud to offer microneedling with SkinPen ®. By creating millions of controlled microchannels in the skin, SkinPen jump-starts the production of collagen and elastin. Many of us desire youthful, radiant skin, and microneedling has emerged as a leading treatment option. Why Choose SkinPen?

Dermatology 52

Dermatology Production 52

pharmaphorum

OCTOBER 27, 2020

CEO Vas Narasimhan said on a call this morning that Novartis is anticipating a strong final quarter, although COVID-19 is still pegging back sales of some product lines, notably dermatology, ophthalmology and the retail business of its Sandoz generics unit.

Sales 98

Sales Gene Therapy Dermatology Gene 98

Pharmaceutical Technology

FEBRUARY 18, 2023

Novartis Overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Antibody Development 100

pharmaphorum

OCTOBER 1, 2021

Further details from the study – which involved four doses of either a high or low dose of the antibody over a 12-week period and a clinical assessment at 16 weeks – were presented at the EADV dermatology congress this week.

Drugs 103

Drugs Antibody Dermatology Trials 103